Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2024 25 June 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-13-june-2024
Faster access to clinical trial information in Europe 21 June 2024 All news https://www.ema.europa.eu/en/news/faster-access-clinical-trial-information-europe
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2024 14 June 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-may-2024
The list of “never events” is now updated 7 June 2024 All news https://ansm.sante.fr/actualites/la-liste-des-never-events-est-actualisee
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level – Human medicines requirements 3 June 2024 All news Information-member-states-requirement-nomination-phv-contact-person-national-level_21May2024-1Download
Annual report highlights progress in science, medicines and health in 2023 31 May 2024 All news https://www.ema.europa.eu/en/news/annual-report-highlights-progress-science-medicines-health-2023
European regulation on medical devices: end of transition period 27 May 2024 All news https://ansm.sante.fr/actualites/reglement-europeen-relatif-aux-dispositifs-medicaux-fin-de-la-periode-de-transition
Certification of medical devices: a second European notified organization for France 21 May 2024 All news https://ansm.sante.fr/actualites/certification-des-dispositifs-medicaux-un-deuxieme-organisme-notifie-europeen-pour-la-france
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2024 17 May 2024 All news https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-may-2024
Permanent Scientific Committee on Monitoring and Pharmacovigilance – Restricted Expertise Session of 30 January 2024 13 May 2024 All news France-Permanent-Scientific-Committee-for-Pharmaco-Surveillance-_09May2024-ibuprofen-1Download